MYCN gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 Study-Neuroblastoma Study Group of the Société Française d'Oncologie Pédiatrique. - Rubie,H.; Hartmann,O.; Michon,J. (J Clin Oncol, 1997)